Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines

Vaccine

Volumn 26, Issue 35, 2008, Pages 4563-4570

  Prymula, Roman ^a   Chlibek, Roman ^a   Splino, Miroslav ^a   Kaliskova, Eva ^b   Kohl, Igor ^b   Lommel, Patricia ^c   Schuerman, Lode ^c  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b GLAXOSMITHKLINE   (United Kingdom)

^c GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Immunogenicity; Pneumococcal protein D conjugate DTPa HBV IPV Hib combination vaccines; Safety

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HEPATITIS A VACCINE; MATERNAL ANTIBODY; MEASLES MUMPS RUBELLA VACCINE;

AGITATION; ALGORITHM; ALLERGIC REACTION; ANOREXIA; ANTIBODY BLOOD LEVEL; ARTICLE; BLEEDING DISORDER; CLINICAL PROTOCOL; CLINICAL TRIAL; CONJUGATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG SAFETY; DRUG TOLERABILITY; EPILEPSY; EXANTHEMA SUBITUM; FEBRILE CONVULSION; FEMALE; FEVER; GASTROINTESTINAL INFECTION; HAEMOPHILUS INFLUENZAE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; IMMUNE RESPONSE; IMMUNOGENICITY; INFANT; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; IRRITABILITY; LYMPHADENITIS; MALE; MULTICENTER STUDY; NONTHROMBOCYTOPENIC PURPURA; NORMAL HUMAN; PHARYNGITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SIDE EFFECT; VASCULAR DISEASE; VIRUS INFECTION; VOMITING;

ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CARRIER PROTEINS; DOUBLE-BLIND METHOD; FEMALE; HAEMOPHILUS VACCINES; HEPATITIS A VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN D; INFANT; LIPOPROTEINS; MALE; PNEUMOCOCCAL VACCINES; VACCINES, CONJUGATE;

EID: 48449095619     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.05.080     Document Type: Article

References (27)

1. Frenkel L.D., and Nielsen K. Immunization issues for the 21st century. Ann Allergy Asthma Immunol 90 Suppl. (2003) 45-52
2. Elliman D., and Bedford H. Safety and efficacy of combination vaccines. BMJ 326 7397 (2003) 995-996
3. Modlin J.C.D.C. Combination vaccines for childhood immunization. MMWR Recomm Rep 48 RR-5 (1999) 1-14
4. Obaro S.K. The new pneumococcal vaccine. Clin Microbiol Infect 8 10 (2002) 623-633
5. Meyerhoff A, Greenberg D, Jacobs RJ. Effects of a new combination vaccine on childhood immunization coverage rates. www.cdc.confex.com/cdc/nic2004/techprogram/paper 5233.htm. Accessed on 10 October 2006.
6. Ocampo A.F., Biltoft C., Lucero M., Ölander R.M., Ugpo J., Auranen K, et al. Response and persistence of antibodies to PRP-T and DTwP vaccines with concomitant administration of conjugate vaccines. Vaccine 25 4 (2007) 605-611
7. Prymula R., Peeters P., Chrobok V., Kriz P., Novakova E., Kaliskova E., et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typeable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367 9512 (2006) 740-748
8. Dagan R., Amir J., Mijalovsky A., Kalmanovitch I., Bar-Yochai A., Thoelen S., et al. Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody. Pediatr Infect Dis J 19 11 (2000) 1045-1052
9. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19 3 (2000) 187-195
10. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakoski J., Herva E., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344 6 (2001) 403-409
11. Nurkka A., Joensuu J., Henckaerts I., Peeters P., Poolman J., Kilpi T., et al. Immunogenicity and safety of the eleven valent pneumococcal polysaccharide-protein D conjugate vaccine in infants. Pediatr Infect Dis J 23 11 (2004) 1008-1014
12. Tichmann-Schumann I., Soemantri P., Behre U., Disselhoff J., Mahler H., Maechler G., et al. Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 24 1 (2005) 70-77
13. Schmitt H.J., Knuf M., Ortiz E., Sanger R., Uwamwezi M.C., and Kaufhold A. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections. J Pediatr 137 3 (2000) 304-312
14. Tejedor J.C., Omeñaca F., Garcia-Sicilia J., Verdaguer J., Van Esso D., Esporrin C., et al. Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine. Pediatr Infect Dis J 23 12 (2004) 1109-1115
15. Tejedor J.C., Moro M., Ruiz-Contreras J., Castro J., Gomez-Campdera J.A., Navarro M.L., et al. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J 25 8 (2006) 713-720
16. Tichmann I., Preidel H., Grunert D., Habash S., Schult R., Maier R., et al. Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age. Vaccine 23 25 (2005) 3272-3279
17. Zepp F., Knuf M., Heininger U., Jahn K., Collard A., Habermehl P., et al. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants. Vaccine 22 (2004) 2226-2233
18. Ahman H., Kayhty H., Vuorela A., Leroy O., and Eskola J. Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid. Vaccine 17 20-21 (1999) 2726-2732
19. Dagan R., Eskola J., Leclerc C., and Leroy O. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun 66 5 (1998) 2093-2098
20. Dagan R., Melamed R., Zamir O., and Leroy O. Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens. Pediatr Infect Dis J 16 11 (1997) 1053-1059
21. Buttery J.P., Riddell A., McVernon J., Chantler T., Lane L., Bowen-Morris J., et al. Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial. JAMA 293 14 (2005) 1751-1758
22. Pichichero M.E., Bernstein H., Blatter M.M., Schuerman L., Cheuvart B., and Holmes S.J. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine. J Pediatr 151 1 (2007) 43-49 49
23. Shinefield H., Black S., Ray P., Chang I., Lewis N., Fireman B., et al. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J 18 9 (1999) 757-763
24. Kanra G., Yalcin S.S., Kara A., Ozmert E., and Yurdakok K. Hepatitis A booster vaccine in children after infant immunization. Pediatr Infect Dis J 21 8 (2002) 727-730
25. Piazza M., Safary A., Vegnente A., Soncini R., Pasqualina P., Sardo M., et al. Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme. Vaccine 17 6 (1999) 585-588
26. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 48 RR-12 (1999) 1-37
27. Black S.B., Cimino C.O., Hansen J., Lewis E., Ray P., Corsaro B., et al. Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J 25 4 (2006) 306-311